(ASAHI SHIBUN) A major component in liquid glue dramatically increases the effects of cancer radiation therapy, a research team at the Tokyo Institute of Technology has discovered.
The team's findings were released Jan. 23 in the U.S. scientific journal Science Advances.
In a radiation therapy called boron neutron capture therapy (BNCT), a drug made of boron compounds is injected into cancer cells before neutrons are irradiated from outside to destroy those cells.
Advertisement - story continues below
